ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 609 • 2012 ACR/ARHP Annual Meeting

    Peripheral Neuropathy in Systemic Lupus Erythematosus

    Amin Oomatia1, Hong Fang2, Michelle Petri2 and Julius Birnbaum3, 1School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Rheumatology, Johns Hopkins University, Baltimore, MD

    Background/Purpose: Whilst Neurological disorders are a common manifestation of systemic lupus erythematosus (SLE), peripheral neuropathies have received little attention. The literature consists mostly of small…
  • Abstract Number: 610 • 2012 ACR/ARHP Annual Meeting

    B Lymphocyte Stimulator Levels Are Higher in Caucasian SLE Patients Earlier in Disease Course and Predict Damage Accumulation

    Eoghan M. McCarthy1, Ruth Lee1, Joan Ni Gabhann2, Siobhan Smith2, Michele Doran3, Gaye Cunnane3, Donough G. Howard1, Paul G. O'Connell4, Grainne M. Kearns5 and Caroline Jefferies2, 1Rheumatology, Beaumont Hospital, Dublin 9, Ireland, 2Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland, 3Dept of Rheumatology, St. James Hospital, Dublin, Ireland, 4Department of Rheumatology, Beaumont Hospital, Dublin 9, Ireland, 5Rheumatology Department, Beaumont Hospital, Dublin, Ireland

    Background/Purpose: B Lymphocyte Stimulator(BLyS) plays an important role in the pathogenesis of Systemic Lupus Erythematosus(SLE). Whilst trials of anti BLyS-targeted therapy have shown promise, the optimal…
  • Abstract Number: 571 • 2012 ACR/ARHP Annual Meeting

    Description of Distribution of Active Inflammatory Lesions On Magnetic Resonance Imaging of the Sacroiliac Joints and the Spine in Patients with Early Axial Spondyloarthritis – Analysis of the Esther Trial Baseline Data

    In-Ho Song1, Christian Althoff2, Hildrun Haibel1, Joachim Listing3, Anja Weiß4, Bruce Freundlich5, Martin Rudwaleit6 and Joachim Sieper7, 1Medical Department I, Rheumatology, Charité Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany, 2Radiology, Charite Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany, 3German Rheumatism Research Center, Berlin, Germany, 4German Rheumatism Research Centre, Berlin, Germany, 5University of Pennsylvania, Philadelphia, PA, 6Endokrinologikum Berlin, Berlin, Germany, 7Medical Department I, Rheumatology, Charité Universitätesmedizin Berlin, Berlin, Germany

    Background/Purpose: To address the question whether active inflammation starts at specific sites of the sacroiliac joints (SI-joints) and/ or the spine.   Methods: Wb-MRIs of…
  • Abstract Number: 572 • 2012 ACR/ARHP Annual Meeting

    Radiographic Damage in Ankylosing Spondylitis Over 12 Years of Follow-up: A Longitudinal Analysis

    Sofia Ramiro1, Carmen Stolwijk2, A.M. Van Tubergen3, Désirée van der Heijde4 and Robert Landewé5, 1Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, The Netherlands and Hospital Garcia de Orta, Almada, Portugal, 2Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Department of Medicine, Maastricht University Medical Center, Maastricht, Netherlands, 4Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands

    Background/Purpose: Radiographic damage is one of the core outcomes recommended by the Assessment in Spondyloarthritis international Society (ASAS) for follow-up of patients with axial SpA.…
  • Abstract Number: 573 • 2012 ACR/ARHP Annual Meeting

    Differential Association Between Human Leukocyte Antigen (HLA) Alleles and Joint Subluxation and Ankylosis in Patients with Psoriatic Arthritis

    Vinod Chandran1, Arane Thavaneswaran2, Amir Haddad2, Fawnda Pellett3 and Dafna D. Gladman4, 1Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 2Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada

    Background/Purpose: We have previously reported the association between HLA and KIR gene variants with the development of Arthritis Mutilans (AM) in psoriatic arthritis (PsA). However,…
  • Abstract Number: 574 • 2012 ACR/ARHP Annual Meeting

    Long Term Inhibition of Interleukin (IL)-17A with Secukinumab Improves Clinical Symptoms and Reduces Spinal Inflammation As Assessed by Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis

    Xenofon Baraliakos1, Jürgen Braun2, D. D. Laurent3, Dominique L. Baeten4, D. van der Heijde5, Joachim Sieper6, Paul Emery7, Iain B. McInnes8, Jacob M. van Laar9, R. Landewe10, Paul Wordsworth11, Jurgen Wollenhaupt12, Herbert Kellner13, Andrew Wright3, Francois Vandenhende14, Kath Radford15, Babul Borah15 and Hueber Wolfgang15, 1Rheumatology, Rheumazentrum Ruhrgebiet, Herne, Germany, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Novartis Pharma AG, Basel, Switzerland, 4Department of Clinical Immunology and Rheumatology Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 5Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 6Charitè Berlin, Campus Benjamin Franklin, Berlin, Germany, 7Division of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom, 8Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom, 9Newcastle University, Newcastle upon Tyne, United Kingdom, 10Division of Clinical Immunology and Rheumatology, Academic Medical Center / University of Amsterdam, Amsterdam, Netherlands, 11Nuffield Orthopaedic Centre, Oxford, United Kingdom, 12Division of Reheumatology, Schoen-Klinik Hamburg-Eilbek Teaching Hospital of the University of Hamburg, Hamburg, Germany, 13Centre for Inflammatory Joint Diseases, Munich, Germany, Munich, Germany, 14Clinbay, Genappe, Belgium, Genappe, Belgium, 15Novartis Institutes for BioMedical Research, Basel, Switzerland

    Background/Purpose: In a recent proof-of-concept (PoC) trial it was shown that secukinumab, a fully human IgG1k anti-IL17A monoclonal antibody, significantly improved clinical signs and symptoms…
  • Abstract Number: 575 • 2012 ACR/ARHP Annual Meeting

    Profiling of Response to Anti-TNFα Therapy by Serum Markers of Tissue Degradation End Products in Ankylosing Spondylitis Patients

    Anne Sofie Siebuhr1, Anne C. Bay-Jensen2, Morten Asser Karsdal3, Efstathios Vassiliadis4, Stephanie Wichuk5, Claus Christiansen6 and Walter P. Maksymowych7, 1Rheumatology, Nordic Bioscience, Herlev, Denmark, 2Cartilage Biomarkers and Research, Nordic Bioscience, Herlev, Denmark, 3Nordic Bioscience A/S, Herlev, Denmark, 4Nordic Bioscience, Herlev, Denmark, 5Medicine, University of Alberta, Edmonton, AB, Canada, 6CCBR, Ballerup, Denmark, 7Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Chronic inflammatory diseases such as Ankylosing Spondylitis (AS) are diverse and therefore hard to clearly diagnose and treat. Conventional biomarkers for AS, as CRP…
  • Abstract Number: 576 • 2012 ACR/ARHP Annual Meeting

    Reference Intervals of Spinal Mobility Measures in Normal Individuals – the Mobility Study

    Sofia Ramiro1, Carmen Stolwijk2, A.M. Van Tubergen3, Patrick Royston4, Désirée van der Heijde5 and Robert Landewé6, 1Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam, The Netherlands and Hospital Garcia de Orta, Almada, Portugal, 2Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 3Department of Medicine, Maastricht University Medical Center, Maastricht, Netherlands, 4MRC Clinical Trials Unit, University College of London, London, United Kingdom, 5Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 6Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands

    Background/Purpose: Spinal mobility is frequently assessed in the follow-up of patients with axial SpA, which is also in accordance with the recommendations by the Assessment…
  • Abstract Number: 577 • 2012 ACR/ARHP Annual Meeting

    MRI of the Spine for Detection of Bone Spurs and Ankylosis in Patients with Ankylosing Spondylitis: Does MRI Offer Any Advantages Over Radiography?

    Susanne Juhl Pedersen1, Mikkel Østergaard2, Robert GW Lambert3 and Walter P. Maksymowych4, 1Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 2Department of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 3Radiology, University of Alberta, Edmonton, AB, Canada, 4Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: The current gold standard for detection of disease progression in ankylosing spondylitis (AS) is conventional radiography. The most reliable method mSASSS includes the anterior…
  • Abstract Number: 578 • 2012 ACR/ARHP Annual Meeting

    Assessment of the Link Between Inflammation and Fat Metaplasia in Patients with Spondyloarthritis On Non-Biological Therapy: A Long Term Magnetic Resonance Imaging Study

    Zheng Zhao1, Susanne Juhl Pedersen2, Robert GW Lambert3, Stephanie Wichuk4, Mikkel Ostergaard5 and Walter P. Maksymowych6, 1Department of Rheumatology, University of Alberta and PLA General Hospital, Beijing, PR China, Beijing, AB, China, 2Dept. of Rheumatology, Copenhagen Center for Arthritis Research, Copenhagen, Denmark, 3Radiology, University of Alberta, Edmonton, AB, Canada, 4Medicine, University of Alberta, Edmonton, AB, Canada, 5Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Glostrup, Denmark, 6Department of Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: There is growing awareness of the importance of fat metaplasia in the pathogenesis of SpA and its potential link with inflammation and new bone…
  • Abstract Number: 579 • 2012 ACR/ARHP Annual Meeting

    Prevalence of Psoriatic Arthritis in Psoriasis Patients According to Newer Classification Criteria

    Hernan Maldonado-Ficco1, Gustavo Citera1, Ana Alba Porrini2 and Jose A. Maldonado-Cocco1, 1Rheumatology, Instituto de Rehabilitacion Psicofisica - Fundacion Reumatologica Argentina Dr. Osvaldo Garcia-Morteo, Buenos Aires, Argentina, 2Rheumatology, Hospital Argerich, Buenos Aires, Argentina

    Background/Purpose:  To determine the prevalence of Psoriatic Arthritis (PsA) in a cohort of psoriasis patients according to CASPAR criteria, and compare it with that resulting from…
  • Abstract Number: 580 • 2012 ACR/ARHP Annual Meeting

    Changes in Sclerostin, Dickkopf-1 and Serum Markers of Inflammation, Cartilage and Bone Turnover in Patients with Axial Spondyloarthritis Treated with Adalimumab

    Susanne Juhl Pedersen1, Inge Juul Sørensen2, Julia S. Johansen3, Patrick Garnero4, Anne Gitte Loft5, Jens Skoedt6, Gorm Thamsborg7, Karsten Asmussen8, Elka Kluger9, Jesper Nørregaard10, Torben Grube Christensen11 and Mikkel Østergaard12, 1Copenhagen Center for Arthritis Research, Copenhagen University Hospital at Glostrup, Copenhagen, Denmark, 2Department of Rheumatology, Hvidovre Hospital, Copenhagen, Denmark, 3Department of Internal Medicine and Oncology, Herlev Hospital, Herlev, Denmark, 4INSERM, UMR 1033, Lyon and Cisbio Bioassays, Bagnols/Cèze, France, 5Department of Rheumatology, Sygehus Lillebaelt, Vejle, Denmark, 6Department of Rheumatology, Gentofte Hospital, Copenhagen, Denmark, 7Dep. of Rheumatology, Glostrup Hospital, Copenhagen, Denmark, 8Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Denmark, 9King Christian 10th Rheumatism Hospital at Gråsten, Graasten, Denmark, 10Dep of Rheumatology, Hørsholm Hospital, Hørsholm, Denmark, 11Department of Rheumatology, Slagelse Hospital, Slagelse, Denmark, 12Copenhagen University Hospital Glostrup, Copenhagen, Denmark

    Background/Purpose: Few studies have investigated changes in plasma sclerostin and Dickkopf1 (DKK-1) in relation to other biomarkers of inflammation, cartilage and bone turnover during treatment…
  • Abstract Number: 581 • 2012 ACR/ARHP Annual Meeting

    Examining a Role for Th17 Regulation and Toll-Like Receptor Signaling in Psoriatic Arthritis

    Fatima Abji1, Remy Pollock2, Fawnda Pellett3, Vinod Chandran4 and Dafna D. Gladman2, 1University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 3Division of Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada

    Background/Purpose: Psoriatic arthritis (PsA) is a seronegative inflammatory arthritis that develops in 30% of patients with cutaneous psoriasis (PsC). Joint inflammation in PsA is mediated…
  • Abstract Number: 582 • 2012 ACR/ARHP Annual Meeting

    Proteomic Analysis of Synovial Tissue: A Unique Tool to Predict Response to Anti-TNF Alpha Therapy in Patients with Inflammatory Arthritis

    Opeyemi S. Ademowo1, Emily S. Collins1, Cathy Rooney1, A. W van Kuijk2, Danielle M. Gerlag3, Paul P. Tak2, Oliver FitzGerald4 and Stephen R. Pennington1, 1UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin 4, Ireland, 2Clinical Immunology / Rheumatology, Academic Medical Centre/University of Amsterdam, Amsterdam, Netherlands, 3Division of Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 4Department of Rheumatology, St. Vincent's University Hospital, Dublin, Ireland

    Background/Purpose: Inflammatory arthritis, which includes rheumatoid arthritis (RA) and psoriatic arthritis (PsA), is a leading cause of joint deformity, disability and reduced quality of life…
  • Abstract Number: 583 • 2012 ACR/ARHP Annual Meeting

    Familial Aggregation and Heritability of Ankylosing Spondylitis in Taiwan: A Nationwide Population Study

    Chang-Fu Kuo1, Matthew J. Grainge2, Lai-Chu See3, Kuang-Hui Yu4, Shue-Fen Luo4, Ana M. Valdes5, I-Jun Chou6, Weiya Zhang1 and Michael Doherty7, 1Academic Rheumatology, School of Clinical Sciences, University of Nottingham, Nottingham, United Kingdom, 2Division of Epidemiology and Public Health, School of Community Health Sciences, University of Nottingham, Nottingham, United Kingdom, 3Department of Public Health, College of Medicine, Chang Gung University, Taoyuan, Taiwan, 4Division of Rheumatology, Immunology and Allergy, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 5Dept of Twin Research and Genetic Epidemiology, St. Thomas' Hospital, King's College London, London, United Kingdom, 6Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 7Academic Rheumatology, University of Nottingham, Nottingham, United Kingdom

    Background/Purpose: To estimate the risk of ankylosing spondylitis (AS) among individuals with affected first-degree relatives and to assess the magnitude of genetic contribution to the…
  • « Previous Page
  • 1
  • …
  • 2562
  • 2563
  • 2564
  • 2565
  • 2566
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology